You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0086 Receptor Activator of Nuclear Factor Kappa-B Ligand (Rankl) and Sclerostin are Related to Joint Destruction in Early Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
SAT0086 Receptor Activator of Nuclear Factor Kappa-B Ligand (Rankl) and Sclerostin are Related to Joint Destruction in Early Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015100
Jul 2015300
Aug 2015101
Sep 2015500
Nov 2015002
Dec 2015301
Jan 2016200
Feb 2016200
Mar 2016401
Apr 2016801
May 2016300
Jun 2016900
Jul 2016602
Aug 2016300
Sep 2016100
Oct 2016300
Nov 2016100
Dec 2016500
Jan 2017300
Feb 2017300
Mar 2017200
Apr 2017400
May 2017001
Jun 2017900
Jul 2017202
Aug 20171000
Sep 20171200
Oct 2017600
Nov 20171200
Dec 2017600
Jan 20181000
Feb 2018800
Mar 20183401
Apr 2018400
May 20181800
Jun 2018600
Jul 20181600
Aug 2018600
Sep 2018600
Oct 2018600
Nov 2018400
Dec 2018400
Jan 2019200
Feb 2019400
Mar 20191400
Apr 2019200
May 2019600
Jun 2019200
Jul 2019400
Sep 2019200
Oct 2019601
Nov 2019200
Dec 2019200
Feb 2020200
Apr 2020800
May 2020200
Jun 2020800
Jul 2020600
Aug 2020200
Sep 20202800
Oct 20206800
Nov 20207200
Dec 2020800
Jan 2021200
Oct 2021200
Nov 2021600
Dec 2021400
Jan 2022500
Feb 2022800
Mar 2022600
Apr 2022200
May 20221000
Jun 2022500
Jul 20221400
Aug 20222400
Sep 2022600
Oct 2022400
Nov 2022400
Dec 20221200
Jan 2023401
Feb 2023600
Mar 2023200
Apr 2023200
May 2023400
Jun 2023200
Jul 2023600
Aug 20231000
Sep 20231200
Oct 2023200
Nov 2023200
Dec 2023400
Jan 2024200
Feb 2024400
Mar 2024400
Total681014